A retrospective clinicopathological analysis of small-cell carcinoma of the uterine cervix

被引:46
作者
Dongol, Samina [1 ]
Tai, Yanhong [2 ]
Shao, Yi [3 ]
Jiang, Jie [1 ]
Kong, Beihua [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China
[2] Jinan Mil Area Gen Hosp, Jinan, Shandong, Peoples R China
[3] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
small-cell carcinoma of cervix; multimodal treatment regimen; neoadjuvant chemotherapy; prognostic factor;
D O I
10.3892/mco.2013.193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical cancer encompasses several histological types, including neuroendocrine tumors (NETs). Small-cell carcinoma of the uterine cervix (SCCC) is the most common and aggressive subtype of cervical NET. The objective of this case report was to investigate SCCC using a retrospective clinicopathological approach. Four cases of large (>= 4 cm) SCCCs are presented in this case study. The patients were diagnosed with SCCC through a sequential hierarchy of physical examinations, laboratory reports, radiological reports, immunohistochemical and pathological tests. The diagnosis for each case was made at various stages (Ib1, Ib2, IIa2 and IIb, according to the FIGO staging system, 2000) and each of the patients received different multimodality therapeutic regimens. All the patients underwent radical hysterectomy and pelvic lymphadenectomy, followed by adjuvant chemotherapy. Neoadjuvant chemotherapy was administered prior to surgery in two of the patients. The clinical and pathological analyses were assessed using a retrospective measure, maintaining timely follow-ups. SCCC is a rare but serious gynecological malignancy. This condition has a poor prognosis due to its high aggressiveness, high rate of metastases and mortality. Furthermore, the rarity of this disease represents a hindrance to adequate research and development of novel, efficient therapeutic regimens.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 28 条
[1]  
AlboresSaavedra J, 1997, ARCH PATHOL LAB MED, V121, P34
[2]  
BARRETT RJ, 1987, CANCER, V60, P2325, DOI 10.1002/1097-0142(19871101)60:9<2325::AID-CNCR2820600935>3.0.CO
[3]  
2-G
[4]   Neuroendocrine cervical carcinoma:: A diagnostic and therapeutic challenge [J].
Bermúdez, A ;
Vighi, S ;
García, A ;
Sardi, J .
GYNECOLOGIC ONCOLOGY, 2001, 82 (01) :32-39
[5]  
Bian Li-hua, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P63
[6]   Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix [J].
Boruta, DM ;
Schorge, JO ;
Duska, LA ;
Crum, CP ;
Castrillon, DH ;
Sheets, EE .
GYNECOLOGIC ONCOLOGY, 2001, 81 (01) :82-87
[7]   Prognostic factors in neuroendocrine small cell cervical carcinoma - A multivariate analysis [J].
Chan, JK ;
Loizzi, V ;
Burger, RA ;
Rutgers, J ;
Monk, BJ .
CANCER, 2003, 97 (03) :568-574
[8]  
Chang TC, 1998, CANCER, V83, P712, DOI 10.1002/(SICI)1097-0142(19980815)83:4<712::AID-CNCR12>3.0.CO
[9]  
2-V
[10]   Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients [J].
Cohen, Joshua G. ;
Kapp, Daniel S. ;
Shin, Jacob Y. ;
Urban, Renata ;
Sherman, Alexander E. ;
Chen, Lee-may ;
Osann, Kathryn ;
Chan, John K. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (04) :347.e1-347.e6